Clearance Summary
Synchro SELECT Guidewire received FDA 510(k) clearance under submission number K202522, sponsored by Stryker Neurovascular. The device was reviewed via the Special premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2020-09-25.
- Submission: K202522
- Applicant / Sponsor: Stryker Neurovascular
- Clearance pathway: Special
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.1330
- Decision date: 2020-09-25
Classification & Regulation
This clearance is catalogued under FDA product code MOF and 21 CFR 870.1330, within the Cardiovascular review panel as a Class II device.